Search Results 61-70 of 17260 for TNF
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...
... TNF alpha agents. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis Rochester, MN. The purpose of this study is to determine if ...
SW. top of mountain peak. The Mayo researchers will be conducting a range of scientific tests on a team of Everest climbers sponsored by The North Face and ...
... TNF-inhibitors. Correlate local levels of antigen with systemic levels measured in serum using matched patient tissue and blood sample, and correlate local ...
... TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...
Planned to initiate TNF-? antagonist therapy over the course of the study ... TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept within 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.